The headlines of a newspaper on this page were generated automatically by a computer program.
このページのコンテンツは コンピュータプログラム で自動的に作成されています。
JAPANESE MAIN RSS feed RSS feed
updatenews @ hr.sub.jp
本システムについて





WORLD

BUSINESS

SPORTS

TECHNOLOGY

社会

政治

国際

経済

テクノロジー

スポーツ

エンターテイメント

科学
twitter hashtag summary
twitter trend
speech separation
large number Retweet
talking summarization
alarming description

real time translation turndown translation
      . .


      bristol-myers squibb said it will buy diabetes drug maker amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease .
      . .
      pharmaceutical giant bristol-myers squibb announced it will purchase diabetes drug maker amylin pharmaceuticals , inc t for about $7 billion.under the deal , unanimously approved by the boards of directors of both companies , bristol-myers squibb will pay $31 in cash per amylin share and assume amylin's debt and a contractual payment obligation totaling about $1.7 billion , the announcement said.the overall coast of the acquisition will be approximately $7 billion , it said .
      . .
      pharmaceutical giant bristol-myers squibb announced it will purchase diabetes drug maker amylin pharmaceuticals , inc t for about $7 billion.under the deal , unanimously approved by the boards of directors of both companies , bristol-myers squibb will pay $31 in cash per amylin share and assume amylin's debt and a contractual payment obligation totaling about $1.7 billion , the announcement said.the overall coast of the acquisition will be approximately $7 billion , it said .
      bristol-myers squibb said it will buy diabetes drug maker amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease .
      Generated 2012-7-2_3:16





blogsphere accumulation         blog